Haleon (HLN) said Wednesday it is investing 65 million British pounds ($87.3 million) in a new oral health manufacturing facility in Shanghai in a bid to expand production of brands such as Sensodyne and Parodontax in China.

The company targets extending Parodontax distribution to 30 cities by the end of 2027, it said.

Haleon shares were down 1.1% in premarket activity.